Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

53
The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
53
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

209
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
209
Development of Human Microbiota01:30

Development of Human Microbiota

61
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
61
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

233
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
233
Surface Membrane Barriers01:18

Surface Membrane Barriers

3.0K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prebiotic modulation of FMT donor microbiota enhances MASLD-relevant taxa and functions in an in vitro gut model.

Journal of applied microbiology·2026
Same author

Multi-Species Synbiotic Supplementation After Antibiotics Promotes Recovery of Microbial Diversity and Function, and Increases Gut Barrier Integrity: A Randomized, Placebo-Controlled Trial.

Antibiotics (Basel, Switzerland)·2026
Same author

Multi-Species Synbiotic Supplementation Enhances Gut Microbial Diversity, Increases Urolithin A and Butyrate Production, and Reduces Inflammation in Healthy Adults: A Randomized, Placebo-Controlled Trial.

Nutrients·2025
Same author

Probiotic effects on ectoparasitic mite infestations in honey bees (<i>Apis mellifera</i>) are modulated by environmental conditions and route of administration.

Microbiology spectrum·2025
Same author

The impact of progressive chronic kidney disease on hepatic drug metabolism.

Drug metabolism and disposition: the biological fate of chemicals·2025
Same author

Feasibility, safety and tolerability of estrogen and/or probiotics for improving vaginal health in Canadian African, Caribbean, and Black women: A pilot phase 1 clinical trial.

PloS one·2025

Related Experiment Video

Updated: May 4, 2026

Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip
08:15

Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip

Published on: February 16, 2024

3.7K

Modulating the vaginal microbiome: the need for a bridge between science and practice.

Gregor Reid1

  • 1Lawson Health Research Institute.

Seminars in Reproductive Medicine
|January 7, 2014
PubMed
Summary

Urinary and reproductive tract infections in women and girls remain inadequately treated due to outdated medical practices and regulatory hurdles. Advances in microbiome research offer new understanding but are slow to reach clinical application, hindering better patient care.

More Related Videos

Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria
08:53

Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria

Published on: May 25, 2022

5.4K
Efficient Nucleic Acid Extraction and 16S rRNA Gene Sequencing for Bacterial Community Characterization
12:37

Efficient Nucleic Acid Extraction and 16S rRNA Gene Sequencing for Bacterial Community Characterization

Published on: April 14, 2016

40.9K

Related Experiment Videos

Last Updated: May 4, 2026

Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip
08:15

Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip

Published on: February 16, 2024

3.7K
Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria
08:53

Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria

Published on: May 25, 2022

5.4K
Efficient Nucleic Acid Extraction and 16S rRNA Gene Sequencing for Bacterial Community Characterization
12:37

Efficient Nucleic Acid Extraction and 16S rRNA Gene Sequencing for Bacterial Community Characterization

Published on: April 14, 2016

40.9K

Area of Science:

  • Microbiology
  • Women's Health
  • Medical Technology

Background:

  • Urinary and reproductive tract infections (URTIs) affect millions of women and girls annually.
  • Current diagnostic and treatment methods for URTIs have remained largely unchanged for 40 years and are often inadequate.
  • Development of alternative treatments like probiotics faces funding and regulatory challenges.

Purpose of the Study:

  • To highlight the persistent inadequacy of current diagnostic and treatment measures for URTIs in women and girls.
  • To discuss the barriers hindering the development and implementation of novel alternatives, such as probiotics.
  • To emphasize the potential of human microbiome research to revolutionize understanding and treatment of URTIs.

Main Methods:

  • Review of existing diagnostic and treatment protocols for URTIs.
  • Analysis of regulatory and funding landscapes for alternative therapies.
  • Exploration of recent advancements in human microbiome research relevant to URTIs.

Main Results:

  • Current medical interventions for URTIs have seen minimal advancement in four decades.
  • Bureaucratic and regulatory obstacles, alongside funding issues, impede the progress of alternative treatments.
  • Human microbiome studies are providing novel insights into host-microbe interactions relevant to URTIs.

Conclusions:

  • There is a critical need for updated regulatory frameworks and increased funding to facilitate the development of new URTI treatments.
  • Integrating findings from human microbiome research into clinical practice is essential for improving patient care.
  • Bridging the gap between scientific innovation and healthcare practice is crucial to address the ongoing suboptimal care for women and girls with URTIs.